Laganà, Marta
 Distribuzione geografica
Continente #
NA - Nord America 933
EU - Europa 771
AS - Asia 218
AF - Africa 4
OC - Oceania 2
SA - Sud America 1
Totale 1.929
Nazione #
US - Stati Uniti d'America 925
PL - Polonia 220
IT - Italia 186
FI - Finlandia 87
DE - Germania 85
HK - Hong Kong 72
CN - Cina 64
IE - Irlanda 59
UA - Ucraina 42
SG - Singapore 40
VN - Vietnam 24
GB - Regno Unito 23
CZ - Repubblica Ceca 20
SE - Svezia 17
BE - Belgio 11
IN - India 11
FR - Francia 9
CA - Canada 8
CH - Svizzera 5
JP - Giappone 3
PT - Portogallo 3
RU - Federazione Russa 3
ZW - Zimbabwe 2
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
NL - Olanda 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 1.929
Città #
Warsaw 220
Fairfield 121
Ashburn 94
Chandler 92
Helsinki 81
Hong Kong 72
New York 54
Seattle 48
Wilmington 46
Princeton 45
Woodbridge 43
Cambridge 38
Houston 38
Dalmine 35
Jacksonville 35
Boardman 34
Brescia 26
Dublin 25
Dong Ket 24
Munich 23
Singapore 23
Beijing 22
Menlo Park 22
West Jordan 20
Shanghai 18
Brno 17
Ann Arbor 15
Milan 14
Los Angeles 13
Naples 12
Brussels 11
Romola 11
Pune 8
Turin 8
Des Moines 7
London 7
San Diego 7
Dearborn 6
Lappeenranta 6
Livorno 6
Chicago 5
Rome 5
Toronto 5
Jinan 4
Leipzig 4
Washington 4
Changsha 3
Dietikon 3
Gumyojicho 3
Olomouc 3
Redwood City 3
Rockville 3
San Francisco 3
Shenyang 3
Berlin 2
Borås 2
Brooklyn 2
Cornuda 2
Falkenstein 2
Gardone Val Trompia 2
Gunzenhausen 2
Leawood 2
Lisbon 2
Melfi 2
Nanjing 2
New Bedfont 2
Ningbo 2
Norwalk 2
Parma 2
Phoenix 2
Pianello del Lario 2
Poli 2
S. Pietro 2
Salò 2
San Felice A Cancello 2
Taizhou 2
Würzburg 2
Acton 1
Amora 1
Amsterdam 1
Arcore 1
Ardabil 1
Augusta 1
Bosio 1
Calcinato 1
Caserta 1
Chiswick 1
Cinisello Balsamo 1
Clifton 1
Dallas 1
Delaware 1
Delhi 1
Forest City 1
Fuzhou 1
Guangzhou 1
Hebei 1
Hounslow 1
Huzhou 1
Hyderabad 1
Islington 1
Totale 1.567
Nome #
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 165
Immunotherapy failure in adrenocortical cancer: where next? 157
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 124
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 100
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 100
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 99
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 93
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 88
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 79
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 76
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases 65
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 55
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 51
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 48
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 47
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 44
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 43
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 40
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 39
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 38
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 35
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 35
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 32
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 30
Progression of vertebral fractures in patients with adrenocortical carcinoma undergoing mitotane therapy 30
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 28
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 22
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 21
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 20
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 20
Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 18
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 18
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 15
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 14
Gastrointestinal Toxicity of Antibody Drug Conjugates (ADCs) in Metastatic Breast Cancer: A Pooled Analysis 13
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 13
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients 13
Oncological treatment administration at end of life: a retrospective study 12
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 10
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study 10
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma 9
Letter re: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study 8
null 5
The Evolving Treatment Landscape of Medullary Thyroid Cancer 4
Changes in body composition in early breast cancer patients treated with aromatase inhibitors 4
Totale 1.990
Categoria #
all - tutte 14.298
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.298


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020251 0 0 6 11 18 31 25 31 28 35 29 37
2020/2021477 22 32 45 57 35 63 20 51 31 52 26 43
2021/2022275 20 10 7 66 15 12 13 11 13 36 23 49
2022/2023249 31 16 18 15 19 51 4 27 26 8 17 17
2023/2024598 25 19 45 53 54 93 19 32 89 39 15 115
2024/2025104 54 31 19 0 0 0 0 0 0 0 0 0
Totale 1.990